Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zinc Supplementation on Botulinum Toxin for Overactive Bladder
NCT07405554Phase 2Recruiting
- Sponsor
- Endeavor Health
- Start
- Feb 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Zinc citrate in overactive bladder (OAB), sponsored by Endeavor Health. Started Feb 2026; status: recruiting.
02
Drugs
Zinc citrate
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT07405554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07405554.